HIV-1 Therapeutics Market Projected To Expand At A CAGR Of 1.4% For The Forecast Period From 2018 To 2025 : Grand View Research Inc.

San Francisco, 29 May 2019: The Report Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Analysis By Drug Class (Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs), Non-NRTIs, Entry & Fusion, Protease, Integrase Inhibitors, Coreceptor Antagonists), And Segment Forecasts, 2018 – 2025

The global HIV-1 therapeutics market is expected to reach a value of USD 15.8 billion by 2025, growing at a CAGR of 1.4%. According to a new report by Grand View Research, Inc., HIV continues to be one of the most challenging public health issues worldwide.

The key factors responsible for driving the market growth include the increasing incidence of HIV infections especially amongst the youth due to unprotected sexual practices, exposure to needles or syringes contaminated with infected body fluids or tissues, lack of awareness regarding transmission risk factors, etc.The estimated number of people suffering from HIV in 2015 was recorded to be more than 35 million according to AVERT, a UK-based HIV and AIDS charity.

HIV has vastly affected people from developing and under developed countries, mainly the Asian and African regions. As this infection is not curable at present, the primary aim of antiretroviral therapy is to suppress viral replication in patients usinganti-retroviral agents that are grouped into six different drug classes based on their mechanism of action.

The combination therapy entails medicines from at least two to three drug classes as each class targets different steps in the HIV lifecycle. The combination of drugs is chosen based on patients’ medical history, predisposition to adverse effects of antiretroviral drugs, co-infections with other diseases, and others.

Access Research Report ofHIV-1 Therapeutics Market @ www.grandviewresearch.com/industry-analysis/human-immunodeficiency-virus-hiv-1-therapeutics-market

Further Key Findings from the Study Suggest:

• NRTIs were the largest class of drugs available in the market in 2015 accounting for over 40% of total drugs available in this vertical
• Integrase inhibitors segment is expected to be the fastest growing class of antiretroviral drugs owing to the expected launch of additional integrase inhibitors by major players such as Gilead Sciences, In. and Merck & Co., Inc.
• In 2015, North America held the largest market share in 2015 with a share of over 35%. Easier access to diagnostic facilities is one of the key factors supporting sector expansion in this region.
• Asia Pacific is projected to be the fastest growing regional segment and will retain its position over the forecast period owing to the enhancing healthcare infrastructure and presence of suitable government initiatives favoring growth
• Gilead Sciences, Inc. was the leader in HIV-1 therapeutics sector with respect to market share and drug portfolio, followed byViiV Healthcare in 2015. In addition, in the coming years other small players are expected to enter this sector with their pipeline drugs.
• Other important players in this industry include AbbVie, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., and Boehringer Ingelheim GmbH.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the HIV-1 Therapeutics market by drug class and region:

HIV-1 Therapeutics Drug Class Outlook (Revenue, USD Million; 2014 – 2025)

• Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
• Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
• Entry and Fusion Inhibitors
• Protease Inhibitors (PIs)
• Integrase Inhibitors
• Coreceptor Antagonists

HIV-1 Therapeutics Regional Outlook (Revenue, USD Million; 2014 – 2025)

• South Africa
• Europe
• Asia Pacific
• Latin America
• MEA

Access Press Release of HIV-1 Therapeutics Market @ www.grandviewresearch.com/press-release/global-human-immunodeficiency-virus-hiv-1-therapeutics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

U.S. Medical Copper Tubing Market Segmented On The Basis Of Tubing Type, Application, And End Use : Grand View Research Inc.

San Francisco, 29 May 2019: The Report U.S. Medical Copper Tubing Market, By Tubing Type (Type K, Type L, DWV), By Application (Oxygen, Nitrogen, Carbon Dioxide, Nitrous Oxide), By End Use (Hospitals, Outpatient Facilities, Dentists), And Segment Forecasts, 2018 – 2025

The U.S. medical copper tubing market is expected to reach USD 0.7 billion by 2025, according to a new report by Grand View Research, Inc. Advantages of copper tubing system over traditional system for medical gas supply and presence of advanced & sophisticated healthcare infrastructure in the U.S. are some of the major factors propelling industry growth. In addition, compliance with the regulatory standards help manufacturers produce and market their products by ensuring the quality and safety of products. Thus, the demand for these products is expected to gain momentum in near future.

Strategic collaborations and partnerships continue to be seen in this sector. Also, the leading vendors have focused on strengthening their distribution channel by expanding their distribution centers and service centers, which is expected to fuel the industry growth in the long run. However, risks associated with installation of copper tubing and intense competition among vendors are major factors restraining the growth of this market.

Access Research Report of U.S. Medical Copper Tubing Market @ www.grandviewresearch.com/industry-analysis/us-medical-copper-tubing-market

Further Key Findings from the Study Suggest:

• The type K tubing segment was the highest revenue generating segment of the market in 2015.
• The demand for type K tubing is high and is expected to remain on the rise during the forecast period due to its frequent use in medical copper tubing system. Thus, the boost in demand of this product taking into account its high price is a vital factor contributing to the sector’s largest share in the market.
• The oxygen application is estimated to be the largest shareholder segment due to its huge demand in hospitals and critical care centers in 2015.
• The above segment’s highest share is attributed to the presence of a large patient base suffering from chronic diseases, such as chronic obstructive pulmonary disease and heart diseases.
• The hospital segment led the overall industry in terms of revenue in 2015. The continuous supply of medical gas is essential in hospitals, primarily in ICU, OT, and CCU. Thus, there is an escalating demand for copper tubing in hospitals, which is expected to drive the sector growth.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the U.S. medical copper tubing market on the basis of tubing type, application, and end use:

U.S. Medical Copper TubingMarket Type Outlook (Revenue, USD Million; 2014 – 2025)

• Type K
• Type L
• DWV

U.S. Medical Copper Tubing Market Application Outlook (Revenue, USD Million;2014 – 2025)

• Oxygen
• Medical air
• Nitrogen
• Carbon dioxide
• Nitrous oxide
• Medical vacuum

U.S. Medical Copper Tubing Market End-use Outlook (Revenue, USD Million; 2014 – 2025)

• Hospitals
• Outpatient facilities
• Dentists

Access Press Release of U.S. Medical Copper Tubing Market @ www.grandviewresearch.com/press-release/us-medical-copper-tubing-market-analysis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

MicroRNA (miRNA) Market 2018 Insights Business Opportunities, Current Trends and Forecast 2025 : Grand View Research Inc.

San Francisco, 29 May 2019: The Report MicroRNA (miRNA) Market Size, Share & Trends Analysis Report By Research Tools, By Application (Cancer, Neurological Disease, Immunological Disorder, Infectious Diseases) By End-use, And Segment Forecasts, 2018 – 2025

The global MicroRNA (miRNA) Market size is expected to reach USD 626.27 million by 2025, according to a new report by Grand View Research, Inc., posting a CAGR of 18.6% during the forecast period. A significant role of microRNAs in regulating gene expression. Their rapid adoption in development of diagnostic & prognostic tools for various cancer types is anticipated to provide a fillip to the market.

Recent innovations in miRNA applications such as their use as potential biomarkers in advanced diagnostics have accelerated new product development. Based on existing technologies used in gene analysis such as microarrays, qRT-PCR, and sequencing, new products are being developed for better usage of miRNA. These are designed to overcome challenges faced when working with miRNA.

Investments in development of therapeutics & diagnostic tests based on miRNAs have increased tremendously over past few years. Regulus Therapeutics, Rosetta Genomics, Alnylam Pharmaceuticals, miRagen Therapeutics, and Mirna Therapeutics are some major companies involved in the development of RNA-based therapeutics. These players are involved in strategic partnerships to enhance their capabilities. For instance, in February 2018, STA Pharmaceutical Co., Ltd., a manufacturer of technology platform for small molecule pharmaceutical development signed an agreement with Regulus Therapeutics to provide its manufacturing facility to the company.

Academic & government research organizations are key revenue contributors as large number of microRNA research is carried out in these institutes. However, rising interest of biotech & pharmaceutical companies in miRNAs as biomarkers, especially in cancer screening, is providing a significant push to the market. MiRNA regulating gene expressions in Alzheimer’s diseases, Autism Spectrum Disorders (ASD), Schizophrenia, and Parkinson’s diseases have been identified. Soaring need for easy diagnosis of these diseases is projected to further increase demand for miRNA research tools.

Instruments used in miRNA analysis, especially those based on advanced technology, are expensive. However, processes performed are available at reasonable prices through service providers. MiRNA analysis is a part of genomic analysis, thereby many service providers for the genomics market have extended their service offering to this market as well. Novel approaches for handling targeted delivery of miRNAs are being developed. Nanoparticle-based delivery and miRNA conjugation with other small molecules are few of the potential approaches being studied. Focus on development of approaches to overcome challenges in the delivery of miRNA therapeutics is estimated to propel the market over the forecast period.

Access Research Report of MicroRNA (miRNA) Market @ www.grandviewresearch.com/industry-analysis/microrna-market

Further Key Findings from the Report Suggest:

• Growing competition among miRNA-based therapeutic companies to develop tests & biomarkers for clinical use is likely to boost the demand for miRNA detection services
• Rapid high-quality results coupled with declining sequencing prices are poised to drive adoption of NGS services for miRNA functional studies.
• North America dominated the microRNA market owing to presence of large scale genetic research programs being conducted by universities in the U.S. and Canada. MiRNA profiling studies in these regions are supported by international public functional genomic data repositories such as Gene Expression Omnibus
• Asia Pacific is projected to witness phenomenal CAGR owing to rapid progress in precision medicine & genomics. Owing to the immense potential in APAC, international players are adopting M&A strategies to consolidate their position in the region
• The market is moderately consolidated and competitive in nature due to presence of several multinational players
• Some key companies present in the market are Thermofisher Scientific (Life Technologies); Agilent Technologies; Merck KGaA; QIAGEN (Exiqon); and NanoString Technologies; Inc. The prominence of these players can be attributed to their well-established technical capabilities in other fields of biotechnology.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the global microRNA market on the basis of research scope, application, end-use, and region:

MicroRNA Research Tools Outlook (Revenue, USD Million, 2014 – 2025)

• Services
  • Sample collection
    • Whole Blood
    • Serum
    • Plasma
  • miRNA cDNA Synthesis
  • Profiling & Purification
  • Detection
  • Functional Studies
    • NGS
    • Microarray
    • Real Time PCR
    • Others
  • Products
    • Instruments
    • Kits, Reagents, & Consumables
      • Isolation & Purification
      • Quantification & Detection
      • Functional Analysis
      • Others

MicroRNA Application Outlook (Revenue, USD Million, 2014 – 2025)

• Cancer
• Infectious Diseases
• Immunological Disorder
• Cardiovascular Disease
• Neurological Disease
• Others

MicroRNA End-use Outlook (Revenue, USD Million, 2014 – 2025)

• Biotechnology and Pharmaceutical Companies
• Academic & Government Research Institutes
• Others

MicroRNA Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Access Press Release of MicroRNA (miRNA) Market @ www.grandviewresearch.com/press-release/global-microrna-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Medical Holography Market Value To Reach USD 4.04 Billion By 2025 : Grand View Research Inc.

San Francisco, 29 May 2019: The Report Medical Holography Market Analysis Report By Product (Holographic Display, Microscope, Print, Software), By Application (Biomedical Research, Medical Education), By End-use, And Segment Forecasts, 2018 – 2025

The global  size is expected to reach USD 4.04 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 31.0% during the forecast period. The market is predominantly driven by increasing adoption of this technique in biomedical research and academic centers. Rising awareness regarding benefits of the technique is one of the key growth stimulators of the market.

Benefits associated with holographic techniques are precise coordination in interventional and diagnostic applications, generation of live images, minimal invasion, and enhanced training. Soaring demand for incorporation of minimally invasive techniques is also projected to boost the growth of the global market. As compared to invasive procedures, these procedures result in lesser trauma and quicker recovery. Another advantage of this procedure is that there is less amount of blood loss as compared to invasive surgery.

Medical holography is anticipated to revolutionize education and training for medical students over the coming years. Traditional teaching methods and textbooks increase the cognitive load on students, which can be reduced by conversion of 2 or 2.5 D representation into a 3D image. According to a study, it has been observed that medical holograms improve the understanding of anatomy compared to traditional methods. Moreover, holographic projections are increasingly being used in various other fields such as aviation, manufacturing, gas, and oil which is estimated to augur well for the holography market.

With increasing burden of chronic diseases and clinical urgency to incorporate technologically advanced products for early and non-invasive diagnosis, medical holography is likely to gain prominence in a wide array of applications. Introduction of new and sophisticated products is poised to shape the future of the market.

Access Research Report of Medical Holography Market @ www.grandviewresearch.com/industry-analysis/medical-holography-market

Further key findings from the study suggest:

• The holographic displays segment accounted for 65.8% of the overall revenue in 2016
• Semi-transparent displays held 38.8% of the holographic display segment as they can be used to create 3D graphics with enhanced depths and sufficient resolution to provide realistic experience
• The microscope segment is expected to witness a remarkable CAGR of 32.3% during the forecast period due to technological advancements in the field of microscopy
• The medical education segment is poised to post a CAGR of 31.6% during the forecast period
• Research laboratories was the dominant end-use segment, commanding a share of 32.97% in 2016. The substantial share can be attributed to increasing adoption of holography products in research, which primarily involves phase contrast imaging and dynamic live cell imaging
• North America led the market with over 37.0% share in 2016 owing to extensive research activities undertaken by a majority of prominent market players
• Asia Pacific is anticipated to exhibit a CAGR of over 32.5% during the forecast period.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the global medical holography market on the basis of product, application, end use, and region:

Medical Holography Product Outlook (Revenue, USD Million, 2014 – 2025)

• Holographic Display
  • Laser
  • Touchable
  • Piston
  • Semi-Transparent
• Microscope
• Print
• Software
• Others

Medical Holography Application Outlook (Revenue, USD Million, 2014 – 2025)

• Medical Imaging
  • Ophthalmology
  • Dentistry
  • Urology
  • Otology
  • Orthopedics
  • Others
• Medical Education
• Biomedical Research

Medical Holography End Use Outlook (Revenue, USD Million, 2014 – 2025)

• Academic Centers
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinics
• Research Laboratories

Medical Holography Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Access Press Release of Medical Holography Market @ www.grandviewresearch.com/press-release/global-medical-holography-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Clinical Trials Management System (CTMS) Market Anticipated To Expand At A CAGR Of 12.1% For The Forecast Period From 2018 To 2025 : Grand View Research Inc.

San Francisco, 29 May 2019: The Report Clinical Trials Management System (CTMS) Market Share, Size & Trends Analysis Report By Type (Enterprise, Site), By Delivery Mode (Web-based, Cloud-based), By Component, By End User, And Segment Forecasts, 2018 – 2025

The global Clinical Trials Management System (CTMS) Market size is expected to reach USD 1.62 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 12.1% over the forecast period. Rapid growth of healthcare IT, high R&D expenditure by life science and clinical research organizations, and adoption of CTMS solutions is anticipated to drive the market growth.

Increasing investment by pharmaceutical and biotechnology companies coupled with government funding is promoting research activities. This factor is expected to boostgrowth of the market for clinical trial management systems.According to the estimates of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), global research-based pharmaceutical industry has spent around USD 149.8 billion in 2015. The annual spending of pharmaceutical industry is 5.5 times greater than the aerospace industry, 1.8 times more than software and computer services andsoftware industry, and 5 times more than chemicals industry.

Access Research Report of Clinical Trials Management System (CTMS) Market @ www.grandviewresearch.com/industry-analysis/clinical-trial-management-system-ctms-market

Further key findings from the study suggest:

• Enterprise CTMS held the largest market share in 2016 due to the benefits such as real-time insight into operational activities and efficient tracking in tracking and managing the regulatory process
• Web-based systems held the largest market share in 2016 owing to the benefits such as remote access of data and minimal technical issues
• Cloud based system is anticipated to exhibit the fastest CAGRover the forecast period. Real-time data tracking, high security, easy accessibility from any device, and privacy are a few factors attributed to the growth
• Based onregion, North America is expected to continue holding the largest market share during the forecast period due to high adoption of advanced technology and improved healthcare infrastructure
• Asia Pacificis likely to witness significant growthover the next decade due toincreasing government incentives and low cost of clinical trials
• Some of the key players operating in the Clinical Trials Management System (CTMS) market are Surgery Partners;PARAXEL International Corporation; Oracle Corporation; Medidata Solutions Inc.; Forte Research Systems Inc.; Medpace Holdings Inc.; and Clinical Data Inc.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the global Clinical Trials Management System (CTMS) market based on type, delivery mode, component, end user, and region:

Clinical Trials Management System (CTMS) Type Outlook (Revenue, USD Million, 2014 – 2025)

• Enterprise
• Site

Clinical Trials Management System (CTMS) Delivery Mode Outlook (Revenue, USD Million, 2014 – 2025)

• Web-based
• Cloud-based
• On-Premise

Clinical Trials Management System (CTMS) Component Outlook (Revenue, USD Million, 2014 – 2025)

• Software
• Services

Clinical Trials Management System (CTMS) End-User Outlook (Revenue, USD Million, 2014 – 2025)

• Pharmaceutical and Biotechnology Firm
  • Johnson & Johnson
  • Roche
  • Novartis
  • Pfizer
  • Merck
  • GlaxoSmithKline
  • Novo Nordisk
  • Amgen
  • Bristol Myesr Squibb
  • Sanofi
• CROs
• Medical Device Firm

Clinical Trials Management System (CTMS) Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Access Press Release of Clinical Trials Management System (CTMS) Market @ www.grandviewresearch.com/press-release/global-clinical-trial-management-system-ctms-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

In vivo CRO Market Share And Trends To Reach Industry Size With USD 5.81 Billion By 2026 : Grand View Research Inc.

San Francisco, 29 May 2019: The Report In vivo CRO Market Size, Share & Trends Analysis Report By Product Type, By GLP Type, By Indication (Diabetes, Obesity, Autoimmune/Inflammatory, CNS Conditions), And Segment Forecasts, 2019 – 2026

The global In vivo CRO Market is anticipated to reach USD 5.81 billion by 2026, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% during the forecast period. Increasing focus on core competencies by the pharmaceutical players coupled with economic efficiency offered for outsourcing is expected to boost the demand.

In Addition, the CROs are equipped with a competent workforce capable of performing a diverse number of tasks along with being well-versed through regulatory requirements. Also, the pressure from the increasing competition owing to rapid growth of generics, patent expirations, and introduction of biosimilar equivalents are encouraging pharmaceutical companies to take the aid of such organizations.

Increasing mergers and collaborations have propelled the value of pharmaceutical outsourcing with major industry contributors expanding into developing regions. The year 2015 experienced high valued transactions as a result of LabCorp acquiring Covance for USD 5.5 billion and the Chinese Private Equity Group acquiring WuXifor USD 3.3 billion. The patent cliff, high research and development cost involved, and globalization in the clinical trial process has driven the market.

Access Research Report of In vivo CRO Market @ www.grandviewresearch.com/industry-analysis/in-vivo-cro-market

Further key findings from the report suggest:

• Rodent based In vivo CRO led the market in 2018 and is anticipated to remain dominant throughout the forecast period. Mice is the most used animal for preclinical evaluation and accounted for almost 76% of the market share in 2018.
• Based on indication, oncology held the largest market share in 2018, attributed to the increasing number of cancer cases and focus of pharmaceutical players on introducing novel drug treatments with fewer side-effects
• North America led the global In vivo CRO market in 2018 owing to the presence of technologically advanced CROs
• Asia Pacific is anticipated to register the fastest CAGR over the forecast period. Constantly improving healthcare infrastructure, huge patient base, presence of untapped opportunities, and economic development, are some factors responsible for the rapid growth
• Some of the key market players include Pharmaceutical Product Development, LLC (PPD); IQVIA; American Preclinical Services, LLC.; Charles River Laboratories; Parexel International Corporation; ICON Plc; Covance Inc.; Theorem Clinical research; inVentiv Health; WuXi AppTec, Inc.; American Preclinical Services, LLC.; and Evotec (US), Inc. Partnership and mergers and acquisitions are the key strategic undertakings by these players

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global In vivo CRO market based on product type, GLP type, indication, and region:

In vivo CRO Product Type Outlook (Revenue, USD Million, 2015 – 2026)

• Rodent Based
  • Rats
  • Mice
  • Others
• Non-Rodent Based
  • Hamsters
  • Guinea Pigs
  • Gerbils
  • Others

In vivo CRO GLP Type Outlook (Revenue, USD Million, 2015 – 2026)

• Non GLP
  • In House
  • Outsourcing
• GLP Toxicology
  • In House
  • Outsourcing

In vivo CRO Indication Outlook (Revenue, USD Million, 2015 – 2026)

• Autoimmune/Inflammatory Conditions
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Osteoarthritis
  • Irritable Bowel Syndrome
  • Others
• Pain Management
  • Chronic Pain
  • Acute Pain
• Oncology
  • Blood Cancer
  • Solid Tumor
    • Syngeneic Model
    • Patient Derived Xenograft
    • Xenograft
  • Others
• CNS conditions
  • Epilepsy
  • Parkinson’s Disease
  • Huntington’s Disease
  • Stroke
  • Traumatic Brain Injury
  • ALS
  • Muscle Regeneration
  • Others
• Diabetes
• Obesity
• Others

In vivo CRO Regional Outlook (Revenue, USD Million, 2015 – 2026)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Access Press Release of In vivo CRO Market @ www.grandviewresearch.com/press-release/global-in-vivo-cro-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

Pharmacovigilance Market Value To Reach USD 11.64 Billion By 2026 : Grand View Research Inc.

San Francisco, 28 May 2019: The Report Pharmacovigilance Market Size, Share & Trends Analysis Report By Clinical Trial Phase (Pre-Clinical, Phase I, II, III, IV), By Service Provider (In-House, Contract Outsourcing), By Type, By End Use, And Segment Forecasts, 2019 – 2026

The global Pharmacovigilance Market size is expected to reach USD 11.64 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 13.3% during the forecast period. Increasing incidence of Adverse Drug Reactions (ADR) is the key growth driver. The U.S. Food and Drug Administration (FDA) received approximately 253,017 serious adverse events and 44,693 deaths associated with ADRs in 2015. This shows the potential demand for implementing safety and Pharmacovigilance (PV) services.

According to the World Health Organization’s (WHO) report on pharmaceuticals consumption, medicines to treat chronic diseases accounted for a larger proportion of the total volume of drug consumption in non-hospital set ups. Owing to this, there has been a significant rise in the number of medicines made available to healthcare consumers. Rising demand for drugs has significantly heightened the need for the development of novel therapeutics via extensive clinical trials, which is expected to serve this market with lucrative opportunities.

Major pharmaceutical companies are involved in extensive R&D initiatives for development of innovative therapeutic molecules. This has resulted in increased drug development activities. Manufacturers are now focusing on remodeling their product development processes in an attempt to cater to patient needs across the globe. These factors are anticipated to fuel the demand for pharmacovigilance services during the forecast period.

Moreover, leading pharma companies in developed countries are focusing on outsourcing PV service in an attempt to reduce cost and to minimize operational expenses. This is anticipated to serve as an opportunity for contact research organizations in developing regions to gain more revenue share.

The companies operating in the pharmacovigilance market are undertaking strategic initiatives such as collaborations with the PV service providers to gain access to medical information and to manage PV workflows. For instance, In April 2017, Accenture entered in a collaborative agreement with BioCelebrate to develop a platform for aggregating and analyzing clinical information for improved drug developing efficiency, thus enhancing its R&D capabilities. These factors are anticipated to fuel the market growth.

Access Research Report of Pharmacovigilance Market @ www.grandviewresearch.com/industry-analysis/pharmacovigilance-industry

Further key findings from the study suggest:

• Phase IV held a dominant market share owing to the extensive post marketing surveillance of pharmaceuticals and increasing number of ADR incidences in the market
• Phase III is anticipated to witness lucrative CAGR owing to increasing focus of pharmaceutical manufacturers on therapeutic development and safety monitoring
• In service provider segment, contract outsourcing held a significant market share, owing to shift in focus of pharmaceutical companies to outsourcing services to reduce operational cost
• Based on type of service, spontaneous reporting held the largest market share owing to its wide application in pharmacovigilance and benefits such as easy simulation of data sets for better drug comparison
• Research organizations segment is anticipated to exhibit lucrative CAGR over the forecast period owing to increasing R&D for the development of novel biologics and medical devices
• Asia Pacific pharmacovigilance market is anticipated to showcase lucrative CAGR in the forthcoming years
• Industry participants are focusing on increasing R&D activities to develop better pharmacovigilance services.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the global pharmacovigilance market on the basis of the clinical trial phase, service provider, type of methods, end use, and region:

Pharmacovigilance Clinical Trial Phase Outlook (Revenue, USD Million, 2014 – 2026)

• Pre-clinical
• Phase I
• Phase II
• Phase III
• Phase IV

Pharmacovigilance Service Provider Outlook (Revenue, USD Million, 2014 – 2026)

• In-house
• Contract Outsourcing

Pharmacovigilance Type of Methods Outlook (Revenue, USD Million, 2014 – 2026)

• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining

Pharmacovigilance End Use Outlook (Revenue, USD Million, 2014 – 2026)

• Hospitals
• Research Organizations
• Industrial

Pharmacovigilance Regional Outlook (Revenue, USD Million, 2014 – 2026)

• North America
  • S.
  • Canada
• Europe
  • K.
  • Germany
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

Access Press Release of Pharmacovigilance Market @ www.grandviewresearch.com/press-release/global-pharmacovigilance-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Cancer Diagnostics Market Is Expected To Reach USD 249.6 Billion By 2026 : Grand View Research Inc.

San Francisco, 28 May 2019: The Report Cancer Diagnostics Market Analysis Report By Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy), By Application (Breast, Lung, Liver, Cervical, Colorectal, Skin), By Region, And Segment Forecasts, 2019 – 2026

The global Cancer Diagnostics Market size is expected to reach USD 249.6 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a 7.0% during the forecast period. Continual introduction of innovative products, coupled with increasing need for early diagnosis of various diseases, is a prime factor driving the market. In addition, rapid growth of the healthcare and diagnostics sector can be attributed to penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering demand for these screening tests and imaging modalities used for monitoring disease progression.

Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early cancer diagnosis. In addition, cancer research organizations, along with public and private entities, are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease much before the symptoms appear.

Furthermore, giant players are collaborating with governments and other agencies to enhance patient accessibility to these tests and products. For instance, Illumina, Inc. launched a new venture called GRAIL with investors, Jeff Bezos and Bill Gates, with an investment of more than USD 100 million. GRAIL is mainly focused on blood-based oncological screening for timely diagnosis of the most common tumor types through simple laboratory tests. 

Access Research Report of Cancer Diagnostics Market @  www.grandviewresearch.com/industry-analysis/cancer-diagnostics-market

Further key findings from the report suggest:

• Rapid adoption of technology and escalating need for early diagnosis is augmenting the growth of imaging systems. Thus, the segment is expected to exhibit the fastest CAGR at 8.0% during the forecast period
• The breast cancer segment accounted for the largest share based on application due to high incidence rate of breast cancer triggering the need for its early diagnosis
• In 2018, North America dominated the global space with the largest revenue share of 42.0%. Focused research efforts in oncology for development of early tumor detection tools, coupled with grants from government healthcare agencies, are contributing to a strong medical ecosystem to fight cancer in this region
• Asia Pacific is expected to emerge as the fastest growing region during the forecast period. Favorable regulatory framework and growing patient pool in India, China, and Japan due to support in diagnostic process at comparatively lower prices are some of the factors boosting the market growth in this region
• Major players competing in this market include GE Healthcare; Abbott; Hoffmann-La Roche Ltd.; and Siemens Healthcare GmbH. Other prominent players include but are not limited to Becton Dickinson & Company; Illumina, Inc.; Koninklijke Philips N.V.; and Hologic, Inc.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the global cancer diagnostics market on the basis of type, application, and region:

Cancer Diagnostics Type Outlook (Revenue, USD Billion, 2014 – 2026)

• Laboratory Tests
• Genetic Tests
• Imaging
• Endoscopy
• Biopsy
• Others (barium enema)

Cancer Diagnostics Application Outlook (Revenue, USD Billion, 2014 – 2026)

• Breast Cancer
• Colorectal Cancer
• Cervical Cancer
• Lung Cancer
• Prostate Cancer
• Skin Cancer
• Blood Cancer
• Kidney Cancer
• Liver Cancer
• Pancreatic Cancer
• Ovarian Cancer
• Others

Cancer Diagnostics Regional Outlook (Revenue, USD Billion, 2014 – 2026)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)

Access Press Release of Cancer Diagnostics Market @ www.grandviewresearch.com/press-release/global-cancer-diagnostics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Intrapartum Monitoring Devices Market Size To Hit USD 2.83 Billion By 2025 : Grand View Research Inc.

San Francisco, 28 May 2019: The Report Intrapartum Monitoring Devices Market Analysis Report, By Product (Monitors, Electrodes (Fetal Scalp Electrodes, Intrauterine Pressure Catheter, Transducer for Fetal Heart Rate)), By Region, And Segment Forecasts, 2018 – 2025

The global Intrapartum Monitoring Devices Market is expected to reach USD 2.83 billion by 2025, according to a new report by Grand View Research, Inc. The rising occurrences of preterm birth are resulting in increased infant mortality. The mortality rates differ across the globe, owing to the disparities of income, and lack of access to appropriate maternal care facilities in different regions. The regions with larger lower income groups face the highest infant mortality rates due to inadequate availability of obstetric monitoring and other infant care facilities. Effective maternal and postnatal care can help save more than 3 quarters of the premature babies.

According to the reports of WHO, annually 15.0 million infants are born premature. This number has been observed to be on a rise in the past few years. There are multiple causes for premature deliveries, such as high blood pressure, chronic conditions, infections, multiple pregnancies, early induction of labor. Hence, propelling the need for obstetric devices across the globe.

Rising awareness regarding availability of screening and monitoring procedures, growing prevalence of obesity & Gestational   Diabetes Mellitus (GDM) and increasing demand for improved intrapartum devices are expected to propel the market over the forecast period. 

Access Research Report of Intrapartum Monitoring Devices Market @ www.grandviewresearch.com/industry-analysis/intrapartum-monitors-market

Further key findings from the study suggest:

• The growing prevalence of obesity, rising preterm birth rate and increasing need for critical obstetric care is primarily driving the market growth
• The electrodes dominated the market, owing to their affordability, higher adoption volume and repeat purchase.
• The monitors segment is expected to exhibit fastest growth over the forecast period owing to the technological advancements.
• North America dominated the market in 2016, owing to rising prevalence of obesity and diabetes, various government initiatives creating awareness regarding rising incidences of preterm births, availability of monitoring test options, and highly developed healthcare infrastructure.
• Constant rise in the cases of preterm births and infant mortality rates are observed in Asia Pacific. Thus, this region is expected to witness a rapid growth during the forecast period.
• The key players of the market include Analogic Corporation, GE Healthcare, Koninklijke Philips N.V.; Medtronic plc; CooperSurgical, Inc.; Stryker, and Olympus Corporation.
• These players hold a strong position in market with their strategic initiatives such as mergers and acquisitions, partnerships with small/local players to expand their geographic foothold and widening of product portfolio by sharing the technology and products.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the intrapartum monitoring devices market report on the basis of device type and region:

Device Type Outlook (Revenue, USD Million; 2014 – 2025)

• Monitors
• Electrodes
  • Fetal Scalp Electrodes
  • Intrauterine Pressure Catheter
  • Transducer for FHR
  • Transducer for Uterine Contractions

Regional Outlook (Revenue, USD Million; 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

 Access Press Release of Intrapartum Monitoring Devices Market @ www.grandviewresearch.com/press-release/global-intrapartum-monitoring-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

Vascular Grafts Market Accounted At USD 3.30 Billion By 2026 : Grand View Research Inc.

San Francisco, 28 May 2019: The Report Vascular Grafts Market Size, Share & Trends Analysis Report By Product (Peripheral, Endovascular Stent), By Application (Vascular Occlusion, Cardiac Aneurysms), By Raw Material (PTFE, Polyester), And Segment Forecasts, 2019 – 2026

The global Vascular Grafts Market size is projected to reach at USD 3.30 billion by 2026 expanding at a CAGR of 6.4%, according to a report by Grand View Research, Inc. Endovascular stent grafts dominated the market in 2018 and is expected to be the second fastest-growing segment over the forecast period. Increasing prevalence of cardiovascular aneurysms is the leading cause of rise in demand for endovascular stent grafts. Low levels of physical activity, sedentary lifestyle, and substance abuse are some of the key factors leading to the high prevalence of renal and Cardiac Diseases (CVDs) globally. The impact of these factors is especially high in developed economies, such as North America and Europe. However, it is expected to shift towards emerging regions, such as Asia Pacific and Latin America, owing to changing demographics.

Key factors attributed to higher impact in these countries are increasing prevalence of aforementioned diseases in geriatric population, rising disposable income, and changing lifestyle patterns. Polytetrafluoroethylene (PTFE) raw material segment led the global market in 2018 with a revenue of USD 710.3 million. The segment is anticipated to expand at the fastest CAGR over the forecast period on account of PTFE graft’s advantages, such as protection against delamination and minimal blood loss. Asia Pacific is expected to be the fastest-growing market with a CAGR of 7.5% over the forecast period due to increasing public and private healthcare expenditure and availability of healthcare insurance across urban and rural centers.

Access Research Report of Vascular Grafts Market @ www.grandviewresearch.com/industry-analysis/vascular-graft-market

Further key findings from the study suggest:

• Endovascular stent grafts led the market in 2018 as a result of increased prevalence of cardiac aneurysms caused due to sedentary lifestyle and other occupational factors.
• PTFE grafts led the raw materials segment in 2018 owing to their advantages, such as minimal blood loss and maximum protection against delamination.
• Moreover, technological advancements in PTFE-based products is anticipated to drive the segment further.
• North America was the dominant regional market with a revenue of USD 620.9 million owing to high prevalence of CVDs and kidney diseases
• The region is projected to maintain the dominance in future due to the presence of advanced healthcare facilities and reimbursement policies.
• Some of the key companies in this market include Medtronic, plc; LeMaitre Vascular Inc.; Terumo Corp.; Getinge AB; W.L. Gore and Associates, Inc.; and Cook Medical, Inc.
• These companies focus on technological innovations, new product launches, and regional expansion to gain a competitive edge.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global vascular grafts market on the basis of product, application, raw material, and region:

Vascular Grafts Product Outlook (Revenue, USD Million, 2014 – 2026)

• Hemodialysis Access
• Endovascular Stent
• Peripheral

Vascular Grafts Application Outlook (Revenue, USD Million, 2014 – 2026)

• Cardiac Aneurysms
• Kidney Failure
• Vascular Occlusion

Vascular Grafts Raw Material Outlook (Revenue, USD Million, 2014 – 2026)

• Polyester-based
• Polytetrafluoroethylene-based
• Polyurethane based
• Biological Materials-based
  • Human Saphenous and Umbilical Veins
  • Tissue Engineered Materials

Vascular Grafts Regional Outlook (Revenue, USD Million, 2014 – 2026)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Access Press Release of Vascular Grafts Market @ www.grandviewresearch.com/press-release/vascular-graft-market-analysis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com